Wecare's BLa80: China's Sole Infant Whitelist & Dual FDA GRAS Probiotic Pioneer Drives Industry to New Standards
Beijing, China – July 30, 2025 – Wecare Probiotics announced the successful conclusion of its pivotal seminar, "Clinically Validated + Potency Guaranteed + Officially Registered: Driving Probiotic Products Back to Fundamentals." The event specifically highlighted the groundbreaking inclusion into the Infant Food Whitelist of the BLa80 strain.BLa80 now stands as the only probiotic strain in mainland China to be included on the National Health Commission's Infant Food Strain Whitelist, while also holding both FDA GRAS and self-affirmed GRAS status. Key aspects of the seminar on BLa80’s inclusion include:Segmented Clinical Study Design: Trials are meticulously stratified across infant age groups (0-6 months, 7-12 months...
